Correlation Between Nuvalent and Apogee Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Nuvalent and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nuvalent and Apogee Therapeutics, Common, you can compare the effects of market volatilities on Nuvalent and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Apogee Therapeutics,.

Diversification Opportunities for Nuvalent and Apogee Therapeutics,

0.39

Correlation Coefficient

Nuvalent  Apogee Therapeutics,

Weak diversification

The 3 months correlation between Nuvalent and Apogee is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of Nuvalent i.e., Nuvalent and Apogee Therapeutics, go up and down completely randomly.

Pair Corralation between Nuvalent and Apogee Therapeutics,

Given the investment horizon of 90 days Nuvalent is expected to generate 0.59 times more return on investment than Apogee Therapeutics,. However, Nuvalent is 1.68 times less risky than Apogee Therapeutics,. It trades about -0.02 of its potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about -0.03 per unit of risk. If you would invest  7,787  in Nuvalent on December 29, 2024 and sell it today you would lose (425.00) from holding Nuvalent or give up 5.46% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Nuvalent  vs.  Apogee Therapeutics, Common

Nuvalent

Risk-Adjusted Performance

Very Weak

Over the last 90 days Nuvalent has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Nuvalent is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Apogee Therapeutics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Pair Trading with Nuvalent and Apogee Therapeutics,

The main advantage of trading using opposite Nuvalent and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.

The idea behind Nuvalent and Apogee Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.